Back to Search
WILLIAM HARKER, M.D.
M.D.
Hematology & Oncology Physician
NPI: 1679522569Individual
Specialties, Licenses & Credentials
Hematology & Oncology PhysicianPrimary
Internal Medicine — Hematology & Oncology
Code: 207RH0003X
171684-1205(UT)
Research & Publications (4)
Zoledronic acid inhibits adjuvant letrozole-induced bone loss in postmenopausal women with early breast cancer.
PMID 17159193·J Clin Oncol·2007
4-observational
Detailed analysis of a randomized phase III trial: can the tolerability of capecitabine plus docetaxel be improved without compromising its survival advantage?
PMID 16966367·Ann Oncol·2006
3-trial
Multicenter Phase II study of estramustine phosphate plus weekly paclitaxel in patients with androgen-independent prostate carcinoma.
PMID 14770430·Cancer·2004
3-trial
A comparison of independent living outcomes following traumatic brain injury and spinal cord injury.
PMID 12021596·Int J Rehabil Res·2002
4-observational
Data courtesy of the U.S. National Library of Medicine (NLM). Ltrl is not affiliated with or endorsed by NLM.
Contact & Hours
- Address
- 3838 S 700 E, STE 100
SALT LAKE CITY, UT 84106 - Phone
- (801) 269-0231
Quick Facts
- NPI
- 1679522569
- Entity Type
- Individual
- Gender
- Male
- Medicare
- Not confirmed
- Specialties
- 1
- Locations
- 1
- Publications
- 4
Are you this provider?
Claim Your Profile